600216-基本财务实时评分详情
浙江医药600216基本财务实时评分详情
更新时间:2021-09-20 00:00:01
股票代码
600216
当期评分
股票名称
浙江医药
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)0.60080.46340.7720.7720.772
销售净利润率(%)4.77064.144810.878210.878210.8782
销售毛利率(%)40.917939.762541.106841.106841.1068
净资产收益率(%)4.774.368.268.268.26
营业增长率(%)20.48562.72.06972.06972.0697
净利润增长率(%)36.597-10.773771.640571.640571.6405
每股收益(%)0.380.360.4460.650.15
现金流量比率(%)30.72521.810922.159631.63548.1352
三项费用比重(%)27.803228.007720.432921.820122.6029
每股净资产(¥)7.9228.14487.59517.78818.2988
流动比率(%)2.5082.45742.39392.32192.4719
速动比率(%)1.87651.75771.751.70111.8605
现金比率(%)79.051462.315681.733878.725578.7255
总资产利润率(%)3.29822.86083.86745.58661.3188
主营利润比重%632.9711704.621281.3281324.6732312.723
应收账款(万元)125,915.57141,322.05138,915.99144,818.23137,050.47
应收票据(万元)28,078.0919,239.6616,567.5915,631.4320,223.84
预付款项(万元)3,290.664,803.066,409.015,065.966,234.68
存货(万元)119,200.10143,483.46146,958.88146,231.38131,183.06
在建工程(万元)40,179.2446,684.4756,621.4968,389.3549,802.96
应付款项(万元)77,632.4175,749.3780,986.5360,036.6966,354.97
长期借款(万元)1,177.10--70,073.7250,058.725,000.00
未分配利润(万元)412,431.72437,986.59384,860.01404,209.97452,830.37
商誉(万元)505.53--------
流动资产(万元)531,420.16532,327.73526,685.13531,339.90533,185.75
流动负债(万元)188,741.38205,057.76228,235.94235,533.99214,577.33
浙江医药600216评分结果
57.58分
卖出/减持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006